Bioethics News

Proposal to increase chemical abortion by telemedicine in the United States

We must not forget all the medical and ethical difficulties that accompany abortion and, of course, chemical abortion.

At the present time, the states of Mississippi, Missouri, and South and North Dakota in the United States have only one abortion clinic per state, which of course makes it difficult to access this procedure. To try to facilitate access to abortion, abortion by telemedicine is being promoted in the United States, which would circumvent the need for women who decide to abort to visit an abortion clinic. Technically, what is being promoted is chemical abortion by telemedicine using mifepristone and misoprostol within the first 10 weeks of pregnancy, a practice that can be carried out in the woman’s home. Nonetheless, this method has the disadvantage that when it fails (approximately 5% of the time), the woman must undergo a medical examination, which of course will have to be performed in a medical centre (JAMA 176; 585-586, 2016). Aside from these sociological and medical considerations, however, we must not forget all the medical and ethical difficulties that accompany abortion and, of course, chemical abortion.

Foto: Shtterstock

La entrada Proposal to increase chemical abortion by telemedicine in the United States aparece primero en Observatorio de Bioética, UCV.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.